µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º W|6.gN
]
}S9uh-j6l
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ u]<`y6=&C
h}%yG{'/M=
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) [jF\"#A
9-?kamA
1. ICAM-1 %/wfY Rp*
^j'vM\^`ml
2. interleukin 12(IL-12) @TnAO8Q>XD
7
P]Sc
3. tumor infiltrating lymphocyte =_d-MJy~6
MP`WU} 2
4. TCR/CD3 complex m} nA-
*
\8SHX
5. hematopoietin receptor family kN$L8U8f
&?7+8n&+
6. individual idiotype(IdI) Xc
Q'(
_xXDvBU
7. integrin bq`0$c%hN
%LZf=`:(
8. colony-stimulatory factor (CSF) 2BIOA#@t
~TALpd
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© zgHF-KEV
qxglA*/
[
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? '^.}5be&
!Pb39[f
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ 5VPP 2;J
pxs`g&3yd
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠT1r^.;I:
o*WI*Fb'
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ k`Ifd:V.y
:S
|)
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) ZN?UkFnE
dq
~=P>
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ t Sf`
g:nU&-x#R
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) ?QXo]X;f&
a<K@rgQ
3. immunoglobulin superfamily (IgSF) ~8G<Nw4*\
nY<hfqof
4. selectin ?(CMm%(8
fX2PteA0qX
5. anti-idiotypic antibody (¦ÁId) AyMMr_q
Ng3 MfbFG
6. major histocompatibility complex(MHC) (_ElM
>
)d6Ya1vJH
7. immunotolerance Y
+tXWN"8
8y{<M"v+/
8. biological reponse modifier(BRM) NwdA@"YQ|
eOQUy+
9. immune reponse gene (Ir gene) )5
j%."
f9g#pyH4
10. reshaped antibody (or reconstituted antibody) A8R}W=
[$Ld>`3
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© ##!)}i
cFoDR
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ RYaf{i`
V(Ps6jR"BS
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? g(Jzu'
j#b?P=|l
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ $3sS&i<
vb}; _/#?
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? XnQo0
R.PW
<m80e),~
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ }xHoitOD
m[C-/f^u|
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? yk9|H)-z
W$0<a@
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ j3rBEQ,R
-tSWYp{
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ PY.c$)az>
l'(Cxhf.W
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? Te~"\`omJ3
m u(HNj
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ W 0Q-&4
|$":7)eH!
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: Ay!=Yk^~
z_eP
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: [SgP1>M
#"6(Q2|
l
̉񧄤 &3>ki0L
> >wbyj8
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 2s;/*<WM
[zK|OMxoV
1. CD8 9tXLC|yl?
f
5_n
2
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) Nm#VA.~
,:QG%Et
3. immunoglobulin fold(Ig fold) \i "I1xU
"=
H7p3
4. cadherin (Ca-dependent cell adhesion moleculers) 52tIe|KwL
=V_}z3b
5. idiotype-anti-idiotypic antibody immune network theory \*!?\Ko`W
EKk~~PhW 8
6. HLA class II antigen AShJtxxa
R*E/E
7. complementarity-determining region (CDR) NyJU?^f&v
XY1NTo.=
8. perforin(or pore-forming protein ,PFP) vyERt^z
pQ*9)C
9. high affinity IL-2 receptor E$34myOVf
e\ k=T
}
10. artificial active immunization [L|H1ll
+e%9P%[+
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© e1S |&W8
R(=Lhz6R4
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ,`G8U/
i15uHl
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 2K!3+D"
kW4/0PD
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ y;yXOE_
7tfMD(Q]e/
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ yd`xmc)
qWHH%
L;
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ *|Q'?ty(x
?a7PxD.
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? >,y291p2
K\nN2y
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ 5.]+K<:h"A
xSs);XO,
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ gtyo~f
-f#0$Z/0
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ 7!#x-KR~5
wP/&k`HQ#i
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ tlV>
n&D<
l '4
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© F.HD;C-;(
,@tkL!"9q
1. immunoglobulin gene rearrangement <h4"^9hL
=zDU!< U
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) ^rfY9qMJr8
L$cNxz0$
3. flow cytometry(FCM) UZi^ &
%2f``48#
4. carrier effect y{,HpPp#o
X]U,`oE)9
5. positive selection of T lymphocytes in thymus hF s:9
KoRJ'WW^
6. mouse TH1(Th1) and TH2(Th2) subsets &M,a+|yuY
rIH/<@+
7. perforin (pore-forming protein ,PFP) gS _)(
t
9&xk?%{
8. ADCC(antibody-dependent cell-mediated cytotoxicity) rmu5K$pl
_G|hKk^,
9. SH-2(src-homology region 2) HYyO/U9z|I
E0!}~Z)
10. Ab2¦Â (internal image) K#rfQ0QK/!
S<rdPS*P
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© SeN4gr*
oGM Ls
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? Q1jU{
$h`(toTyF
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? '9c`[^
:K>v
F`SM
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ[bk2RaX:i
t~ruP',~\
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ 1rKKp h
R*a5bKr
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠdU1w)Y
$R(?@B(
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) |z\5Ik!fF]
wI><kdz
ÃâÒßѧרҵ£º ,@kD9n5#
mR@|] T
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ tvXoF;Yq
^]l^q'?>:
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? fZ1v|
qzS 9ls>>
´«È¾²¡Ñ§×¨Òµ£º rC
fr&>nn
J!5BH2bg
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ _OV\W'RrA
OzY55
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ Atsi}zTR\
g? N~mca$
Ïû»¯×¨Òµ£º Ot}fGiio
WeDeD\zy
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ ^7MhnA
e~R;
2bk
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ?
*z[G+JX
zvjVM"=G
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ L[
l?}\
%pj6[x`@
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© MV
+R $
-c-af%xD
1. Fas(CD95)/FasL 2VmQ%y6e"
vSty.:bY\p
2. common chain of cytokine receptor J)1:jieQ
UjibQl3:m
3 . TCR/CD3 complex uC\FW6K=m
u8ofg
cFYE
4. negaive selection of thymocytes @X`~r8&
d"3S[_U
5. artificial active immune
jVP70c
LhM{LUi
6. anti-idiotypic Jf\lnJTyU8
d:/8P985
7. IgSF ").MU[q%Y
NGYliP,.6
8. Integrin xlPUum-o
TU ]Ed*'&
9. chemokine o
`?0D)/O
}~P%S(zB
10. B7/CD28 [8*Ovd
gfE<XrG
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© d,=Kv
n^|;J*rD
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ 1-Fg_G}|6
34VyR
a
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ ;t47cUm6j
J6x\_]1:*
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ R'a%_sACj>
Q(SVJ
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ xt]Z{:.
\8\)5#?
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
Oq"(oNG@
~82[pY
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ fr'M)ox1
{#q']YDe`
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© `mPmEV<
'^ '4C'J
1. B7/CD28 Tk s;,C
"cjZ6^Hum
2. Th1 subset H e]1<tx
3_=~7B)
8
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© $,08y
L/(e/Jalg
4. antibody affinity maturation k
hT&[!J{>
o
D;
5. AP-1 !8&,GT
;ak3@Uee
6. single chain variable fragment£¨ScFv£© ulFU(%&
#oMbE<//"
7. NK cell receptor 9
[DQ[bL
~\dpD
8. Zinkernagel-Doherty phenomenon LLmgk"
475yX-A
9. Ig fold rh2pVDS
i]GBu
10. CD40/CD40L lp[3z&u
($(6]?J(?7
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© 322W"qduTZ
(Br$(XJoK}
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ cb&y8!ci~
j5z, l
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ Y^LFJB|b4
1W~-C B>
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ j>&n5?
M
Ia].S#
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ EC1q#;:
Te'^O,C)y$
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ xy
mK|
a2/r$Tgm
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ s
cR-|GuZ
js`zQx'
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ @usQ*k
|L;'In
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© CW\o>yh
I#eIm3Y?
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ORQGay
6?*iIA$b
1.Co-stimulators (or co-stimulating molecules) 3\=8tg p
!P@u4FCs
2.NK-kB <eN>X:_N
?P`wLS^;
3.Immunoglobulin superfamily >[|:cz
EoU}@MjM~
4.antigen-presenting cell (APC) gY0*u+LF
Jr17pu(t
5.death domain 2IjqTL
rA=F:N
2
6.CCR and CXCR 7/Lbs
! FHNKh
7.Lectin (or mitogen) "6Dz~5
oPa2GW8
8.Clusters of differentiation, CD) hNx`=D9[7
pbqa
9.B7 family BOwkC;Q[
,}{E+e5jh7
10.Cytotoxic T lymphocyte, CTL) -^#Ix;%
>5^Z'!Z"
11.IL-15 and IL-15 receptor (IL-15R) E/U1g4S
O')Ivm,E
12.MHC restriction bO2$0!=I
[j93Mp
13.Affinity-chromatography @Wx_4LOhf
~]"}s(J;
14.Cyctosprin A, CsA TP^.]IO-
8l='H l
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) Mm6
(Q
%{}Jr`
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© sgCIY:8
+,|-4U@dl
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 aaaC8;.
l>=c]
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ,YkQJ$
cOUO_xp(
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ RIJBHOa
|xf%1(Rl@
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© gcv,]v8
*:&fw'vd,
ÃâÒßѧרҵ£º ]AHUo;(f%
o1n c.2/0J
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ {X"X.`p
+u)'
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 2<988F
Aga7X
@fV(
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ hG
]
j m
.
}=;]=
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) Z2$-},i
Hv`Zc*
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) 3;M!]9ms
*Z0}0<
D@Z
1. ADCC(antibody dependent cell-mediated cytotoxicity) u(~s$EN
l
:5Vu.\,1
2. »·æß¾úËØ(cyclosporin) 9z-"JnM
\agC Q&
3. KIR(killer cell inhibitory receptor) h]=chz
rcbixOT
4. HLDA(human leucocyte differentiation antigen) ~Ep&:c4:D
y~d W=zO
5. Interleukin 18(IL-18) vx4&
;2
m:
^@AR1%d
6. ÕûºÏËØ(integrin) 'v,W
gPe
dHu]wog
7. Fas/FasL ]MHQ"E?
t #AQD]h
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) vbFAS:Y:+
dqe_&C@*O
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) H}@|ucM"\
*H$nydQ:
10. Th1/Th2 ~\/ J&
J^XH^`'
11. »ùÒòÒßÃç(DNAÒßÃç) T-@pTJ !K9
63f/-64?7
12. chemokines and chemokine receptor G'epsD,.bX
u1"e+4f
13. ÃâÒßÄÍÊÜ :.~a[\C@V<
IQ_0[
14. ¹²´Ì¼¤·Ö×Ó WLpn,8qsY
/X:lt^?%I
15. ËÀÍö½á¹¹Óò(death domain) MPB6
VgdkCdWRm_
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) ;L[9[uQ[C
I45A$nV#Q
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? `%=Jsi0.Nq
cC[n~OV
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠe%P;Jj476
H>r-|*n
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î ZChY:I$<
WY,t> 1c
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ Fv: %"P^
98]t"ny [
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå H>]z=w~
Rf^cw}jU
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ qIT{` hX
u
s0'7|{q
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) c 2@@Rd~M
=s]{
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ 8_m9CQ6 i
kn"x[{d
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ aX%Zuyny
h
%s
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£